ScholarIQanswers from OpenAlex & ORCID
Marc DeCongelio
ResearcherPublications, citations & collaboration network
Marc DeCongelio is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Marc DeCongelio have?
ScholarIQindexed works
Marc DeCongelio has 42 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Marc DeCongelio have?
ScholarIQcitation count
Marc DeCongelio has 49 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Marc DeCongelio?
ScholarIQh-index
Marc DeCongelio has an h-index of 4 in OpenAlex.
What is the i10-index of Marc DeCongelio?
ScholarIQi10-index
Marc DeCongelio has an i10-index of 1 in OpenAlex.
What is the ORCID of Marc DeCongelio?
ScholarIQorcid
The ORCID for Marc DeCongelio is on the source record.
What is the OpenAlex record for Marc DeCongelio?
ScholarIQopenalex
The OpenAlex for Marc DeCongelio is on the source record.
What are the most-cited papers on Marc DeCongelio?
ScholarIQmost cited works
Quantifying the impact of symptomatic acute hepatic porphyria on well‐being via patient‐reported outcomes: Results from the Porphyria Worldwide Patient Experience Research (<scp>POWER</scp>) study
Amy K. Dickey, Kristen Wheeden, Desiree Lyon, Sue Burrell, Sean Hegarty, Rocco Falchetto, Edrin R. Williams, Jasmin Barman‐Aksözen, Marc DeCongelio, Alison Bulkley, Joana Matos, Tarek Mnif, Jordanna Mora, John J. Ko, Stephen Meninger, Stephen Lombardelli, Danielle Nance
Treatment Preferences Among Patients with Renal Cell Carcinoma: Results from a Discrete Choice Experiment
Moshe Chaim Ornstein, Lisa Rosenblatt, Xin Yin, Viviana Del Tejo, Sarah Guttenplan, Flavia Ejzykowicz, Kathleen Beusterien, Oliver Will, deMauri Mackie, Grace Skiles, Marc DeCongelio
A global perspective in <scp>second‐line</scp> treatment patterns for patients with advanced esophageal squamous cell carcinoma
Dena H. Jaffe, Joseph Gricar, Marc DeCongelio, deMauri Mackie
The incidence and prevalence of immunoglobulin A nephropathy in the United States
Marc DeCongelio, Sarah Ali, Martina Furegato, Sandipan Bhattacharjee, Ancilla W. Fernandes
Effectiveness of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease in US Clinical Practice With Comparison to Historical Control Data
Ronald D. Perrone, Diana Garbinsky, Sasikiran Nunna, Hema K. Gandhi, Ancilla W. Fernandes, Gabriela Burgos, Abisola Olopoenia, Marc DeCongelio, Martine C. Maculaitis, Xiaolei Zhou